Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 May;41(5):681–688. doi: 10.1038/bjc.1980.129

Monoclonal immunoglobulin light chains in urine of patients with lymphoma.

J Pierson, T Darley, G T Stevenson, M Virji
PMCID: PMC2010299  PMID: 6775652

Abstract

Fourteen of 31 patients with non-Hodgkin's lymphoma or chronic lymphocytic leukaemia had a monoclonal immunoglobulin light chain detectable in their urine. These chains are believed to be synthesized by the B lymphoid cells comprising the tumour. Upon comparing the different cases, the occurrence and amount of monoclonal light chain showed no dependence upon the extent of tumour, the presence of leukaemic component, or exposure to cytotoxic therapy. The method of detection involved purifying the urinary light chains by immunosorption, and examining their electrophoretic distributions so as to distinguish between the homogeneous monoclonal chains and their heterogeneous normal analogues.

Full text

PDF
681

Images in this article

685Fig. 1
on p.685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexanian R., Bergsagel D. E., Migliore P. J., Vaughn W. K., Howe C. D. Melphalan therapy for plasma cell myeloma. Blood. 1968 Jan;31(1):1–10. [PubMed] [Google Scholar]
  2. Awdeh Z. L., Williamson A. R., Askonas B. A. One cell-one immunoglobulin. Origin of limited heterogeneity of myeloma proteins. Biochem J. 1970 Jan;116(2):241–248. doi: 10.1042/bj1160241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Capra J. D., Kehoe J. M. Hypervariable regions, idiotypy, and the antibody-combining site. Adv Immunol. 1975;20:1–40. doi: 10.1016/s0065-2776(08)60205-9. [DOI] [PubMed] [Google Scholar]
  4. Fett F. W., Deutsch H. F. A new lambda-chain gene. Immunochemistry. 1975 Aug;12(8):643–652. doi: 10.1016/0019-2791(75)90209-8. [DOI] [PubMed] [Google Scholar]
  5. Gordon J., Howlett A. R., Smith J. L. Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma. Immunology. 1978 Mar;34(3):397–404. [PMC free article] [PubMed] [Google Scholar]
  6. Grey H. M., Rabellino E., Pirofsky B. Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest. 1971 Nov;50(11):2368–2375. doi: 10.1172/JCI106735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hamblin T., Hough D. Chronic lymphatic leukaemia: correlation of immunofluorescent characteristics and clinical features. Br J Haematol. 1977 Jul;36(3):359–365. doi: 10.1111/j.1365-2141.1977.tb00659.x. [DOI] [PubMed] [Google Scholar]
  8. Hemmingsen L., Skaarup P. The 24-hour excretion of plasma proteins in the urine of apparently healthy subjects. Scand J Clin Lab Invest. 1975 Jul;35(4):347–353. doi: 10.1080/00365517509095751. [DOI] [PubMed] [Google Scholar]
  9. Johansson B., Klein E., Haglund S. Correlation between the presence of surface localized immunoglobulin (Ig) and the histological type of human malignant lymphomas. Clin Immunol Immunopathol. 1976 Jan;5(1):119–132. doi: 10.1016/0090-1229(76)90155-0. [DOI] [PubMed] [Google Scholar]
  10. Lindström F. D., Williams R. C., Jr, Swaim W. R., Freier E. F. Urinary light-chain excretionin myeloma and other disorders--an evaluation of the Bence-Jones test. J Lab Clin Med. 1968 May;71(5):812–825. [PubMed] [Google Scholar]
  11. Lukes R. J., Collins R. D. New approaches to the classification of the lymphomata. Br J Cancer Suppl. 1975 Mar;2:1–28. [PMC free article] [PubMed] [Google Scholar]
  12. Maino V. C., Kurnick J. T., Kubo R. T., Grey H. M. Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin. J Immunol. 1977 Mar;118(3):742–748. [PubMed] [Google Scholar]
  13. Radl J., de Glopper E., de Groot G. A rapid, simple, and reliable technique for preparation of antisera against idiotypes of homogeneous immunoglobulins. Vox Sang. 1978 Jul-Aug;35(1-2):10–12. doi: 10.1111/j.1423-0410.1978.tb02894.x. [DOI] [PubMed] [Google Scholar]
  14. Rudders R. A., Howard J. P. Pathways of human B lymphocyte differentiation: a clonal transition between IgM and IgG synthesis in leukemic B lymphocytes. J Immunol. 1977 Jul;119(1):283–286. [PubMed] [Google Scholar]
  15. SOLOMON A., WALDMANN T. A., FAHEY J. L., MCFARLANE A. S. METABOLISM OF BENCE JONES PROTEINS. J Clin Invest. 1964 Jan;43:103–117. doi: 10.1172/JCI104884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. STEVENSON G. T. Further studies of the gamma-related proteins of normal urine. J Clin Invest. 1962 May;41:1190–1198. doi: 10.1172/JCI104572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stevenson G. T., Straus D. Specific dimerization of the light chains of human immunoglobulin. Biochem J. 1968 Jul;108(3):375–382. doi: 10.1042/bj1080375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Virella G., Da Silva J. J., Lópes-Virella M. F., Parreira F. Cadenas ligeras intracelulares en los linfocitos periféricos de un enfermo con leucemia linfática crónica y proteinuria de Bence-Jones tipo lambda. Sangre (Barc) 1975;20(4):456–466. [PubMed] [Google Scholar]
  19. Waldmann T. A., Strober W., Mogielnicki R. P. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest. 1972 Aug;51(8):2162–2174. doi: 10.1172/JCI107023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wochner R. D., Strober W., Waldmann T. A. The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J Exp Med. 1967 Aug 1;126(2):207–221. doi: 10.1084/jem.126.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES